Work with Patient Registries


The neuromuscular patient registries are a long-established asset of the John Walton Muscular Dystrophy Research Centre (JWMDRC). These longitudinal research databases collect demographic, genetic, clinical, and quality of life data on rare and ultra-rare neuromuscular diseases and use it to provide deidentified data reports or study recruitment support to third parties such as pharmaceutical companies and research groups. The registries support the aims of the JWMDRC by providing valuable data, assisting with patient engagement and recruitment, acting as an interface between patients and the healthcare, scientific and research communities, and ultimately facilitating translational research.

The seven patient registries coordinated from the JWMDRC currently hold data from a combined total of over 4,300 patients in the following disease areas:

Meet the team!

Our email address for general enquiries is [email protected]. Alternatively, you can contact us directly:

Aleks Carver

Data Coordinator

Clinical Research

Helen Walker

Registry Project Manager


Julie Bohill

Registry Project Manager


Lindsay Murphy

Registry Project Manager


Sam McDonald

Registry Project Manager


What can we offer?

To date the registries have supported over 75 registry enquiries, from academics, healthcare professionals, patient organisations and industry.

  • Assist with the rapid identification of participants for clinical trials
  • Contribute to the understanding of the natural history and epidemiology of specific diseases
  • Provide an interface with the research community, enabling dissemination of relevant and disease-specific information to patients and a two-way flow of information
  • Respond to specific research enquiries from academics, healthcare professionals and industry through data analysis and promotion of research studies or clinical trials
  • Inform the understanding and development of standards of care
  • Collect real world data to inform regulatory pathways and monitor the safety and efficacy of new treatments

Let's stay in touch
Join our social media

Cookie consent

We use some essential cookies to make this website work.

We also use cookies set by other sites to help us deliver content from their services, like fonts and maps.

For more details, please see our Cookie Policy